Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

This study has been completed.
Sponsor:
Collaborator:
Isis Pharmaceuticals
Information provided by:
Sanofi
ClinicalTrials.gov Identifier:
NCT00281008
First received: January 20, 2006
Last updated: December 2, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)